ZIMMER BIOMET HOLDINGS, INC.

Seguir

ZBHÚltimo cierre 96.00 USD · Oct 20, 2026

Operaciones de iniciados en ZIMMER BIOMET HOLDINGS, INC.

Operaciones registradas: 3,017; desde Aug 7, 2003

Compras de iniciados: 34; $7.4M

Ventas de iniciados: 337; $2.5B

Iniciados activos · 12 meses: 20; última notificación Oct 5, 2026

Cifras calculadas a partir de notificaciones regulatorias oficiales — .

Datos financieros

Ingresos (12 meses): 8.5B

EBITDA: 2.5B

BPA (12 meses): 4.11

Margen neto: 9.5%

Rentabilidad sobre recursos propios: 6.4%

Crecimiento de ingresos (interanual): 4.8%

Ratio precio/beneficio: 23.11

P/E adelantado: 10.05

Precio / ventas: 2.13

EV / EBITDA: 10.47

Precio / valor contable: 1.37

Rentabilidad por dividendo: 1.0%

Rango 52 semanas: 78.7–105.75

Analistasobjetivo 106.9 USD (+11%) · consenso 3.54/5 · 9 compra · 19 mantener · 0 venta

Propiedadiniciados 0.16% · instituciones 111.36% · posiciones cortas 6.7% del flotante

En USD · a Oct 19, 2026

Iniciados registrados en ZIMMER BIOMET HOLDINGS, INC.

Mostrar los 129 iniciados registrados

Sobre la sociedad

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Iniciado	Notificado	Tipo	Cant.	Precio	Valor · USD	Señales	Fuente	Detalle
Campbell Gary Craig	Oct 5, 2026	Ejercicio	1,218	0.00 USD	n/d (Operación sin contrapartida en efectivo: la notificación indica precio cero (concesión, donación, ejercicio))		SEC

Sector

Healthcare

Actividad

Medical Devices

Mercado de cotización

NYSE

Cotización registradaEstado del valor según la última fuente recibida, no una garantía de negociabilidad.

Nombres anteriores

Periodos registrados en las fuentes consultadas. No certifican las fechas legales de los cambios de nombre.

ZIMMER HOLDINGS INCMar 26, 2001 / Jun 8, 2015

ZIMMER BIOMET HOLDINGS, INC.

Operaciones de iniciados en ZIMMER BIOMET HOLDINGS, INC.

Datos financieros

Iniciados registrados en ZIMMER BIOMET HOLDINGS, INC.

ZIMMER BIOMET HOLDINGS, INC.

Operaciones de iniciados en ZIMMER BIOMET HOLDINGS, INC.

Datos financieros

Iniciados registrados en ZIMMER BIOMET HOLDINGS, INC.

Historial de operaciones de iniciados en ZIMMER BIOMET HOLDINGS, INC.

Sobre la sociedad

Historial de operaciones de iniciados en ZIMMER BIOMET HOLDINGS, INC.